YufeiLiuMDPhD
Radiation Oncology • Duarte, CAGastrointestinal Cancer, Thoracic Cancer
Assistant Professor at City of Hope
Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Duarte Rd.
Duarte, CA 91010
Summary
- Yufei Liu, MD, is a Radiation Oncologist located in Duarte, CA, specializing in gastrointestinal and thoracic cancer. He earned his medical degree from Stanford University School of Medicine and completed a PhD in Molecular and Cell Biology at the University of California, Berkeley. Dr. Liu completed his residency in Radiation Oncology at the University of Texas MD Anderson Cancer Center, where he also served as a resident. Currently an Assistant Professor at City of Hope Comprehensive Cancer Center, Dr. Liu's expertise includes thoracic and gastrointestinal radiation oncology. His research has been published in several journals, including the International Journal of Radiation Oncology, Biology, Physics and the Journal of Thoracic Oncology. He has received several honors, including the IASLC Academy Recipient award in 2024 and a fellowship in lung cancer research from MD Anderson Cancer Center.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2019 - 2023
University of Texas Health Science Center at HoustonInternship, Internal Medicine, 2018 - 2019
Stanford University School of MedicineClass of 2018
University of California, BerkeleyPhD, Molecular and Cell Biology, 2008 - 2014- Princeton UniversityAB, Molecular Biology, 2004 - 2008
Certifications & Licensure
CA State Medical License 2023 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- IASLC Academy Recipient IASLC, 2024
- Jeffrey Lee Cousins Fellowship in Lung Cancer Research University of Texas MD Anderson Cancer Center, 2022
- Best of ASTRO 2020 Abstract American Society for Radiation Oncology, 2020
- Join now to see all
Publications & Presentations
PubMed
- Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials.Alexander D Sherry, Yufei Liu, Pavlos Msaouel, Timothy A Lin, Alex Koong
Medrxiv. 2025-01-13 - 1 citationsConsolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC.Amin H Nassar, Ritujith Jayakrishnan, Jamie Feng, Frances Shepherd, Elio Adib
Journal of Thoracic Oncology. 2025-01-01 - Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies.Adam Grippin, Andy Kim, Yufei Liu, Sage Copling, Ansel Nalin
International Journal of Radiation Oncology, Biology, Physics. 2024-12-12
Journal Articles
- Aging: The Mitochondrial ConnectionBrown K, Liu Y, and Chen, D., Journal of Clinical & Experimental Pathology, 5/21/2012
- Electronic and Vibrational Spectroscopy of Diamondoids and the Interstellar Infrared Bands between 3.35 and 3.55 μmCW Bauschlicher Jr, Y Liu, A Ricca, AL Mattioda, LJ Allamandola, The Astrophysical Journal, 12/10/2007
Books/Book Chapters
Press Mentions
Insights on Navigating the Fragility of Phase 3 TrialsOctober 9th, 2024
Hospitals begin offering breakthrough radiation therapy for metastatic cancer tumorsSeptember 16th, 2024
In Locally Advanced NSCLC, Driver Oncogene Variations Affect Patient OutcomesSeptember 21st, 2022
Professional Memberships
- Member
- Member
- Member
- International Association for the Study of Lung Cancer - IASLCMember
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
